Development of a Novel Tool for the Retrieval and Analysis of Hormone Receptor Expression Characteristics in Metastatic Breast Cancer via Data Mining on Pathology Reports

被引:1
作者
Chang, Kai-Po [1 ,2 ]
Wang, John [2 ]
Chang, Chi-Chang [3 ,4 ]
Chu, Yen-Wei [5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Natl Chung Hsing Univ, PhD Program Med Biotechnol, Taichung 402, Taiwan
[2] China Med Univ Hosp, Dept Pathol, Taichung 404, Taiwan
[3] Chung Shan Med Univ, Sch Med Informat, Taichung 402, Taiwan
[4] Chung Shan Med Univ Hosp, IT Off, Taichung 402, Taiwan
[5] Natl Chung Hsing Univ, Inst Genom & Bioinformat, 145 Xingda Rd, Taichung 402, Taiwan
[6] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan
[7] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan
[8] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung 402, Taiwan
[9] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung 402, Taiwan
[10] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan
关键词
PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; AMERICAN SOCIETY; IMMUNOHISTOCHEMISTRY; TEXT; RECOMMENDATIONS; POPULATION; PATHWAY;
D O I
10.1155/2020/2654815
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Information about the expression status of hormone receptors such as estrogen receptor (ER), progesterone receptor (PR), and Her-2 is crucial in the management and prognosis of breast cancer. Therefore, the retrieval and analysis of hormone receptor expression characteristics in metastatic breast cancer may be valuable in breast cancer study. Herein, we report a text mining tool based on word/phrase matching that retrieves hormone receptor expression data of regional or distant metastatic breast cancer from pathology reports. It was tested on pathology reports at the China Medical University Hospital from 2013 to 2018. The tool showed specificities of 91.6% and 63.3% for the detection of regional lymph node metastasis and distant metastasis, respectively. Sensitivity in immunohistochemical study result extraction in these cases was 98.6% for distant metastasis and 78.3% for regional lymph node metastasis. Statistical analysis on these retrieved data showed significant difference s in PR and Her-2 expressions between regional and metastatic breast cancer, which is compatible with previous studies. In conclusion, our study shows that metastatic breast cancer hormone receptor expression characteristics can be retrieved by text mining. The algorithm designed in this study may be useful in future studies about text mining in pathology reports.
引用
收藏
页数:7
相关论文
共 40 条
[21]   Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor-Positive Breast Cancer [J].
Ramkumar, Charusheila ;
Buturovic, Ljubomir ;
Malpani, Sukriti ;
Attuluri, Arun Kumar ;
Basavaraj, Chetana ;
Prakash, Chandra ;
Madhav, Lekshmi ;
Doval, Dinesh Chandra ;
Mehta, Anurag ;
Bakre, Manjiri M. .
BIOMARKER INSIGHTS, 2018, 13
[22]   Screening of core genes and pathways in breast cancer development via comprehensive analysis of multi gene expression datasets [J].
Bai, Jie ;
Zhang, Xiaoyu ;
Kang, Xiaoning ;
Jin, Lijun ;
Wang, Peng ;
Wang, Zunyi .
ONCOLOGY LETTERS, 2019, 18 (06) :5821-5830
[23]   General Characteristics, Patterns of Relapse and Treatment Outcomes of Patients with HER2 Amplified Metastatic Breast Cancer (MBC) who are Hormone Receptor Positive (HR plus ) Versus Hormone Receptor Negative (HR-) [J].
Dumbrava, Monica I. ;
De Boer, Richard ;
Lok, Sheau ;
Gibbs, Peter ;
Greenberg, Sally ;
Pellegrini, Laura ;
Yip, Desmond ;
Malik, Laeeq .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 :119-120
[24]   First-line fulvestrant plus anastrozole for hormone-receptor-positive metastatic breast cancer in postmenopausal women: a cost-effectiveness analysis [J].
Liao, Weiting ;
Huang, Jiaxing ;
Wu, Qiuji ;
Wen, Feng ;
Zhang, Nan ;
Zhou, Kexun ;
Bai, Liangliang ;
Li, Qiu .
BREAST CANCER, 2020, 27 (03) :399-404
[25]   Prognostic and Predictive Significance of HER2-low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy [J].
Arak, Haci ;
Kus, Tulay .
EUROPEAN JOURNAL OF THERAPEUTICS, 2024, 30 (05) :662-674
[26]   Comparison of Endocrine Therapies in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer: A Network Meta-Analysis [J].
Liu, Siqi ;
Sun, Xin ;
Xu, Xiaohui ;
Lin, Fangcai .
JOURNAL OF BREAST CANCER, 2020, 23 (05) :460-483
[27]   Thyroid hormone receptor alpha (TRa) tissue expression in ductal invasive breast cancer: A study combining quantitative immunohistochemistry with digital slide image analysis [J].
Charalampoudis, P. ;
Agrogiannis, G. ;
Kontzoglou, K. ;
Kouraklis, G. ;
Sotiropoulos, G. C. .
EJSO, 2017, 43 (08) :1428-1432
[28]   Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis [J].
Martel, Samuel ;
Bruzzone, Marco ;
Ceppi, Marcello ;
Maurer, Christian ;
Ponde, Noam Falbel ;
Ferreira, Arlindo R. ;
Viglietti, Giulia ;
Del Mastro, Lucia ;
Prady, Catherine ;
de Azambuja, Evandro ;
Lambertini, Matteo .
CANCER TREATMENT REVIEWS, 2018, 62 :123-132
[29]   A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer [J].
Lloyd, Maxwell R. ;
Chica-Parrado, Rosario ;
Weipert, Caroline M. ;
Knepper, Todd C. ;
Podany, Emily L. ;
Napolitano, Fabiana ;
Ye, Dan ;
Lin, Chang-Ching ;
Uemoto, Yasuaki ;
Liao, Jiemin ;
Wegrzyn, Claire ;
Walko, Christine M. ;
Ryan, Lianne Y. ;
Keenan, Jennifer C. ;
Medford, Arielle J. ;
Liu, Shiyuan A. ;
Wulf, Gerburg M. ;
Clifton, Katherine K. ;
Ma, Cynthia X. ;
Han, Hyo S. ;
Zhang, Nicole ;
Ellisen, Leif W. ;
Bardia, Aditya ;
Arteaga, Carlos L. ;
Hanker, Ariella B. ;
Wanderg, Seth A. .
EBIOMEDICINE, 2025, 118
[30]   Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer [J].
Elton Rexhepaj ;
Donal J Brennan ;
Peter Holloway ;
Elaine W Kay ;
Amanda H McCann ;
Goran Landberg ;
Michael J Duffy ;
Karin Jirstrom ;
William M Gallagher .
Breast Cancer Research, 10